Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on December 2, 2025

Dec. 2, 2025

NewVue Appoints Chris McIntyre as VP of Product & UX to Accelerate Native AI Reporting & Radiologist Cockpit Innovation

EIN Presswire

Dec. 2, 2025

SABER College Announces New Weekend Nursing Program Starting January 26, 2026

EIN Presswire

Dec. 2, 2025

Orlando Rehabilitation Hospital Earns Center of Excellence Designation in Rehabilitation Services and Stroke Care

EIN Presswire

Dec. 2, 2025

Inga Ellzey Billing Companies Brings Dermatology Billing Clarity to 2025 ASDS Annual Meeting

EIN Presswire

Dec. 2, 2025

New Publication in the Journal of Eating Disorders Underscores Within's Leadership in Advancing Remote Treatment

EIN Presswire

Dec. 2, 2025

Clene to Provide CNM-Au8® ALS Program Update

GlobeNewswire

Dec. 2, 2025

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

$Conflicting Guidance and Rapid Innovation Leave Physicians Seeking Clarity in Relapsed/Refractory Multiple Myeloma$

Dec. 2, 2025

Conflicting Guidance and Rapid Innovation Leave Physicians Seeking Clarity in Relapsed/Refractory Multiple Myeloma

GlobeNewswire

Dec. 2, 2025

New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF

GlobeNewswire

Dec. 2, 2025

Publication relating to transparency notifications

GlobeNewswire

Dec. 2, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Dec. 2, 2025

Verano Awarded Conditional License to Commence Vertical Cannabis Operations in Texas

GlobeNewswire

Dec. 2, 2025

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Dec. 2, 2025

Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update

GlobeNewswire

Dec. 2, 2025

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025

GlobeNewswire

Dec. 2, 2025

FISHER HOUSE FOUNDATION RECEIVES “FOUR STARS” FOR 22nd YEAR FROM CHARITY NAVIGATOR, A+ FROM CHARITY WATCH

GlobeNewswire

Dec. 2, 2025

Hawai’i Cancer Care and American Oncology Network Open New Kahului Clinic

GlobeNewswire

Dec. 2, 2025

Migraine Clinical Trial Pipeline Expands as 30+ Companies Driving Innovation in Oncology Therapeutics Space | DelveInsight

GlobeNewswire

Dec. 2, 2025

AMPS Achieves HITRUST e1 Certification, Solidifying Commitment to Data Security in Healthcare

GlobeNewswire

Dec. 2, 2025

Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases

GlobeNewswire